Adhere to the positioning of “hard technology” and pave the way for high-quality development on the Science and Technology Innovation Board

June 20, 2025  Source: drugdu 66

As of June 19th, the "Eight Measures for Deepening the Reform of the Science and Technology Innovation Board to Serve Technological Innovation and the Development of New Quality Productivity" (hereinafter referred to as the "Eight Measures for the Science and Technology Innovation Board") has been implemented for one year. Following the reform path indicated by the "Eight Measures of the Science and Technology Innovation Board", the board further highlights its "hard technology" positioning, and the IPO acceptance and review continue to release positive signals supporting the listing of high-quality "hard technology" enterprises.

Dong Zhongyun, Chief Economist of AVIC Securities, told Securities Daily reporters that the implementation of the "Eight Measures for Science and Technology Innovation Board" has a significant impact on companies listed on the board: improving the financing environment and promoting more qualified technology innovation enterprises to go public smoothly; The inclusiveness of policies enables enterprises to focus more on technological innovation and product research and development, driving overall technological progress in the industry. With the implementation of policies, the market's attention and recognition of the Sci Tech Innovation Board have increased, guiding more resources to flow to the board and promoting the reasonable valuation of Sci Tech Innovation Board companies.

Promote the formation of industrial cluster effects

Since the release of the "Eight Measures for Science and Technology Innovation Board", the regulatory authorities have further introduced "fresh water from the source" to promote high-quality technology-based enterprises to connect with the capital market.

Intelligent imaging company Yingshi Innovation Technology Co., Ltd. was listed on the Science and Technology Innovation Board on June 11th, with a total market value of over 70 billion yuan on the first day of listing. Regarding why a company landed on the Science and Technology Innovation Board, founder Liu Jingkang frankly stated, "To achieve sustained growth, a company must come from early R&D investment and accumulation, and the Science and Technology Innovation Board is the most friendly platform for such technology enterprises

As the main platform supporting "hard technology" enterprises, the Science and Technology Innovation Board provides an important financing platform for enterprises with innovation capabilities and high growth potential. As of the close on June 17th, there were a total of 588 companies listed on the Science and Technology Innovation Board, with over 80% of them coming from key core technology industry chains such as integrated circuits, biomedicine, and high-end equipment. This has gradually formed a clustering and demonstration effect, promoting the optimization and strengthening of related industry chains and helping to form an independent, controllable, safe, and reliable industrial system.

Among them, there are 119 Sci Tech Innovation Board companies in the field of integrated circuits, covering upstream chip design, midstream wafer foundry, and downstream packaging and testing, forming a development pattern with a complete upstream and downstream chain and complete industrial functions.

Many companies on the Science and Technology Innovation Board in the field of integrated circuits are actively building their own industrial chains and promoting high-level self-reliance and self-improvement. For example, Shenzhen Baiwei Storage Technology Co., Ltd., as a storage enterprise, has established a complete independent technology chain from storage solution research and development, main control chip design, advanced packaging and testing to storage testing equipment. Huang Yanfeng, Secretary of the Board of Directors of the company, told Securities Daily reporters, "In the future, the company will continue to deepen the integration of research and development, packaging and testing, and focus on strengthening chip design, advanced packaging and testing, and the construction of testing equipment capabilities

Science and technology innovation board companies in the field of wafer manufacturing and equipment continue to consolidate the foundation of industry independence and controllability, and their production capacity and orders send positive signals. As of the end of the first quarter of this year, several sci-tech innovation board wafer foundry enterprises such as SMIC and Huahong Semiconductor have maintained a high level of capacity utilization, achieving a good situation of both production and sales.

The most touching aspect of the 'Eight Measures for Science and Technology Innovation Board' is holding onto the steering wheel of 'hard technology' with one hand and the promise of 'investor returns' with the other. Cui Shan, Chairman of Zhongkong Technology Co., Ltd., said that with policy guidance, the company has become more resolute in investing funds in research and development after going public, and has taken faster and more stable steps in breakthroughs in core technologies and the transformation of achievements. At the same time, optimized refinancing and merger and acquisition rules allow the company to allocate resources more flexibly, contributing to the company's strategic layout.

Sci Tech Innovation Board companies accelerate 'going global'

Since the release of the "Eight Measures for the Science and Technology Innovation Board", various policy measures for the reform of the board have been steadily promoted. Many companies on the board have accelerated their "going global" pace and enhanced their technological innovation capabilities through tools such as mergers and acquisitions and equity incentives.

Science and Technology Innovation Board companies have diversified their "going global" strategy, deeply integrated into the global industrial chain and supply chain, and competed for the upper reaches of the value chain, showing a positive trend. In 2024, the total overseas revenue of companies listed on the Science and Technology Innovation Board was 430.361 billion yuan, a year-on-year increase of 6.1%; 173 companies' overseas revenue increased by over 30% year-on-year, and 63 companies' products were exported to more than 50 countries and regions.

Currently, the "going global" model of exporting high value-added products and balancing technology and capital has become a new pivot for high-quality development of companies listed on the Science and Technology Innovation Board. For example, Henan Shijia Photon Technology Co., Ltd., an optical chip company, achieved a year-on-year increase of 121% in revenue and 1004% in net profit in the first quarter of 2025, thanks to breakthroughs in mass production of multiple products and the capacity ramp up of its overseas Thai factory; Shengke Nano (Suzhou) Co., Ltd., a third-party semiconductor testing enterprise, has the full chain testing and analysis capabilities of a "chip general hospital". Currently, it has served more than 2000 global customers, covering the entire semiconductor industry chain.

Biopharmaceuticals is also an advantageous industry on the Science and Technology Innovation Board, which has gathered 113 companies and occupies an important position in the global innovative drug field.

Dizhe (Jiangsu) Pharmaceutical Co., Ltd. has successfully launched two innovative drugs with global breakthroughs. During an interview with Securities Daily, Lv Hongbin, the Chief Financial Officer and Secretary of the Board of Directors of the company, stated, "The company participates in global competition, and all products undergo international multicenter clinical research, which requires sustained high R&D investment to continuously improve its core competitiveness. At the same time, the company is actively promoting the global commercialization layout of its products through negotiations and commercial cooperation with potential partners

In order to accelerate the internationalization strategy, enhance overseas financing capabilities, further improve corporate capital strength and comprehensive competitiveness, companies from the Science and Technology Innovation Board in electronics and biomedicine are accelerating their pace of listing in Hong Kong. At present, Sichuan Baili Tianheng Pharmaceutical Co., Ltd., Jiehuate Microelectronics Co., Ltd., Suzhou Naxin Microelectronics Co., Ltd., Shanghai Hehui Optoelectronics Co., Ltd. and other Sci Tech Innovation Board companies have submitted listing applications to the Hong Kong Stock Exchange this year. Sci Tech Innovation Board companies are using their technological innovation "hard power" to accelerate the enhancement of their international competitiveness.

Looking ahead to the future, all parties are full of expectations for the reform of the Science and Technology Innovation Board. Cui Shan said that he hopes the market will have smoother "flowing water" and make the trading on the Science and Technology Innovation Board more active; Second, we hope that the system can better understand scientific and technological innovation, and nurture long-term investment; Three hopes for a more "collaborative" ecosystem, promoting the deep integration of industry, academia, research, and the industrial chain, and jointly climbing the technological peak.

By editor
Share: 

your submission has already been received.

OK

Subscribe

Please enter a valid Email address!

Submit

The most relevant industry news & insight will be sent to you every two weeks.